• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,499.37 757.55
( 0.99%)
Global Indices
Nasdaq
52,499.17 129.78
(0.25%)
Dow Jones
7,562.80 59.09
(0.79%)
Hang Seng
68,634.11 890.26
(1.31%)
Nikkei 225
10,472.08 -16.96
(-0.16%)
Forex
USD-INR
95.15 -0.21
(-0.22%)
EUR-INR
108.73 -0.26
(-0.24%)
GBP-INR
127.27 -0.11
(-0.09%)
JPY-INR
0.59 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Dipna Pharmachem Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543594
INE0MC401013
23.697614
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
6.32
16.61
EPS(TTM)
Face Value()
Div & Yield %
1
10
0
 

Sun Pharmaceutical Industries consolidated net profit rises 26.24% in the March 2026 quarter
May 22,2026
Net profit of Sun Pharmaceutical Industries rose 26.24% to Rs 2714.03 crore in the quarter ended March 2026 as against Rs 2149.88 crore during the previous quarter ended March 2025. Sales rose 13.61% to Rs 14559.75 crore in the quarter ended March 2026 as against Rs 12815.58 crore during the previous quarter ended March 2025.

For the full year,net profit rose 5.04% to Rs 11479.42 crore in the year ended March 2026 as against Rs 10929.04 crore during the previous year ended March 2025. Sales rose 11.87% to Rs 58220.11 crore in the year ended March 2026 as against Rs 52041.25 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales14559.7512815.58 14 58220.1152041.25 12
OPM %27.1629.00 -30.4629.35 -
PBDT4326.814279.82 1 19364.2117005.37 14
PBT3551.343616.03 -2 16426.3614429.98 14
NP2714.032149.88 26 11479.4210929.04 5